Human Immunodeficiency Virus Book


Nucleoside Reverse Transcriptase Inhibitor

Aka: Nucleoside Reverse Transcriptase Inhibitor, Nucleotide Reverse Transcriptase Inhibitor, nRTI, Double nRTI
  1. See Also
    1. Anti-Retroviral Therapy
  2. Indications
    1. Backbone of Anti-Retroviral Therapy (nearly all regimens make use of nRTI agents)
  3. Mechanism
    1. Incorporate into DNA of virus
    2. Stops building process
    3. Resulting DNA incomplete, cannot create new virus
  4. Preparations: Most commonly used nRTI agents
    1. Emtricitabine (FTC)
    2. Lamivudine (Epivir, 3TC)
    3. Tenofovir (Viread, TDF or TAF)
    4. Zidovudine (Retrovir, ZDV or AZT)
  5. Preparations: Other nRTI agents
    1. Abacavir (Ziagen, ABC)
    2. Didanosine (Videx, ddI)
    3. Stavudine (Zerit, d4T)
    4. Zalcitabine (Hivid, ddC)
  6. Preparations: Combination Nucleotide-Nucleoside Reverse Transcriptase Inhibitor (nRTI)
    1. Atripla: Efavirenz (EFV), Emtricitabine (FTC) and Tenofovir (TDF)
    2. Combivir: Lamivudine (3TC) and Zidovudine (ZDV)
    3. Epzicom: Abacavir (ABC) and Lamivudine (3TC)
    4. Trizivir: Abacavir (ABC), Lamivudine (3TC), and Zidovudine (ZDV)
    5. Truvada (or Descovy): Emtricitabine (FTC) and Tenofovir (TDF or TAF)
  7. Combinations: nRTI agents commonly used together
    1. Stavudine (d4T) and Didanosine (ddI)
      1. Consider with Hydroxyurea 500 bid
    2. Stavudine (d4T) and Lamivudine (3TC)
    3. Zidovudine (AZT) and Didanosine (ddI)
    4. Zidovudine (AZT) and Zalcitabine (ddC)
    5. Zidovudine (AZT) and Lamivudine (3TC)
  8. Adverse Effects: Most common
    1. Lactic Acidosis (uncommon, but life-threatening)
      1. My present with Fatigue, GI distress, abnormal Liver Function Tests, elevated Lipase
      2. Stop nRTI immediately if Lactic Acidosis >45 mg/dl occurs (switch to nonthymidine nRTI)
    2. Lipodystrophy
      1. See Lipodystrophy
      2. Associated with prolonged nRTI use and more common with Protease Inhibitors
  9. Adverse Effects: Miscellaneous
    1. See individual agents regarding specific adverse effects
    2. Neuropathy (occurs with 3 D's: DDI, DDC, D4T)
      1. Didanosine (ddI)
      2. Zalcitabine (ddC)
      3. Stavudine (d4T)
    3. Pancreatitis (occurs with 3 D's: DDI, DDC, D4T)
      1. Didanosine (ddI)
      2. Zalcitabine (ddC)
      3. Stavudine (d4T)
    4. Hepatomegaly and Steatosis
      1. (1995) Am J Gastroenterol 90(9):1433-6 [PubMed]
    5. Severe lethal Hypersensitivity Reaction
      1. Abacavir (occurs on rechallenge after reaction)
    6. Gastrointestinal upset or Diarrhea
  10. References
    1. (2009) Treat Guidel Med Lett 7(78): 11-22 [PubMed]

Nucleoside Reverse Transcriptase Inhibitors [MoA] (C1373111)

Concepts Molecular Function (T044)
English Nucleoside Reverse Transcriptase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors [MoA]
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree